Intravenous tissue plasminogen activator in acute branch atheromatous disease: Does it prevent early neurological deterioration?
详细信息 查看全文
- 作者：Min-Gyu Park ; Eun Hye Oh ; Baik-Kyun Kim ; Kyung-Pil Park ; kppark@pusan.ac.kr" class="auth_mail" title="E-mail the corresponding author
- 关键词：Acute stroke ; Antiplatelet agents ; Intravenous thrombolysis ; Tissue plasminogen activator
- 刊名：Journal of Clinical Neuroscience
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：33
- 期：Complete
- 页码：194-197
- 全文大小：337 K
文摘
- •
Early neurological deterioration (END) is not uncommon in patients with branch atheromatous disease.
- •
We evaluated whether tissue plasminogen activator (tPA) can prevent END and improve patient outcome.
- •
Intravenous tPA may not prevent END and guarantee good functional outcome in branch atheromatous disease.
- •
More effective strategies should be evaluated for management of branch atheromatous disease.